Positron Emission Tomography/Computed Tomography in Polymyalgia Rheumatica: When and for What—A Critical Review
Abstract
:1. Introduction
2. PMR, a Condition Associated with Bursal Involvement
3. Is PET-CT Useful for the Diagnosis of PMR?
4. How Can We Detect the Presence of Inflammation in PMR Using PET?
5. PET-Scores: Useful to Differentiate PMR from Other Conditions
6. What about Other Clinical Studies?
7. When Do We Have to Perform 18F-FDG PET-CT?
8. Strengths and Weaknesses of PET-CT in Patients with PMR
9. Potential Correlation between PET-CT and Ultrasonography (US) in PMR
10. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Gonzalez-Gay, M.A.; Vazquez-Rodriguez, T.R.; Lopez-Diaz, M.J.; Miranda-Filloy, J.A.; Gonzalez-Juanatey, C.; Martin, J.; Llorca, J. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009, 61, 1454–1461. [Google Scholar] [CrossRef] [PubMed]
- González-Gay, M.A.; Pina, T. Giant cell arteritis and polymyalgia rheumatica: An update. Curr. Rheumatol. Rep. 2015, 17, 6. [Google Scholar] [CrossRef] [PubMed]
- Lundberg, I.E.; Sharma, A.; Turesson, C.; Mohammad, A.J. An update on polymyalgia rheumatica. J. Intern. Med. 2022, 292, 717–732. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Noltorp, S.; Svensson, B. High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community. Clin. Exp. Rheumatol. 1991, 9, 351–355. [Google Scholar] [PubMed]
- Schaufelberger, C.; Bengtsson, B.; Andersson, R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br. J. Rheumatol. 1995, 34, 261–264. [Google Scholar] [CrossRef] [PubMed]
- Gran, J.T.; Myklebust, G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: A prospective study 1987–1994. J. Rheumatol. 1997, 24, 1739–1743. [Google Scholar] [PubMed]
- Doran, M.F.; Crowson, C.S.; O’Fallon, W.M.; Hunder, G.G.; Gabriel, S.E. Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J. Rheumatol. 2002, 29, 1694–1697. [Google Scholar] [PubMed]
- Crowson, C.S.; Matteson, E.L. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015. Semin. Arthritis Rheum. 2017, 47, 253–256. [Google Scholar] [CrossRef]
- González-Gay, M.A.; García-Porrúa, C.; Vázquez-Caruncho, M.; Dababneh, A.; Hajeer, A.; Ollier, W.E. The spectrum of polymyalgia rheumatica in northwestern Spain: Incidence and analysis of variables associated with relapse in a 10 year study. J. Rheumatol. 1999, 26, 1326–1332. [Google Scholar] [PubMed]
- Salvarani, C.; Macchioni, P.L.; Tartoni, P.L.; Rossi, F.; Baricchi, R.; Castri, C.; Chiaravalloti, F.; Portioli, I. Polymyalgia rheumatica and giant cell arteritis: A 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin. Exp. Rheumatol. 1987, 5, 205–215. [Google Scholar] [PubMed]
- Mattey, D.L.; Hajeer, A.H.; Dababneh, A.; Thomson, W.; González-Gay, M.A.; García-Porrúa, C.; Ollier, W.E.R. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum. 2000, 43, 1749–1755. [Google Scholar] [CrossRef] [PubMed]
- Dababneh, A.; Gonzalez-Gay, M.A.; Garcia-Porrua, C.; Hajeer, A.; Thomson, W.; Ollier, W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J. Rheumatol. 1998, 25, 2140–2145. [Google Scholar] [PubMed]
- Gonzalez-Gay, M.A.; Hajeer, A.H.; Dababneh, A.; Garcia-Porrua, C.; Amoli, M.M.; Llorca, J.; Ollier, W.E. Interferon-gamma gene mi-crosatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin. Exp. Rheumatol. 2004, 22 (Suppl. 36), S18–S20. [Google Scholar] [PubMed]
- Zhao, S.S.; Mackie, S.L.; Larsson, S.C.; Burgess, S.; Yuan, S. Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: Genome-wide meta-analysis and Mendelian randomisation. Rheumatology 2024, keae308. [Google Scholar] [CrossRef] [PubMed]
- Liozon, E.; Parreau, S.; Filloux, M.; Dumonteil, S.; Gondran, G.; Bezanahary, H.; Ly, K.H.; Fauchais, A.L. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review. Autoimmun. Rev. 2021, 20, 102732. [Google Scholar] [CrossRef] [PubMed]
- Manzo, C.; Castagna, A.; Ruotolo, G. Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica? Jt. Bone Spine 2021, 88, 105150. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- González-Gay, M.A.; Matteson, E.L.; Castañeda, S. Polymyalgia rheumatica. Lancet 2017, 390, 1700–1712. [Google Scholar] [CrossRef] [PubMed]
- Espígol-Frigolé, G.; Dejaco, C.; Mackie, S.L.; Salvarani, C.; Matteson, E.L.; Cid, M.C. Polymyalgia rheumatica. Lancet 2023, 402, 1459–1472. [Google Scholar] [CrossRef] [PubMed]
- González-Gay, M.A.; García-Porrúa, C.; Salvarani, C.; Olivieri, I.; Hunder, G.G. Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica. Clin. Exp. Rheumatol. 2000, 18, 755–759. [Google Scholar] [PubMed]
- González-Gay, M.A.; Rodríiguez-Valverde, V.; Blanco, R.; Fernández-Sueiro, J.L.; Armona, J.; Figueroa, M.; Martínez-Taboada, V.M. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate: A more benign syndrome. Arch. Intern. Med. 1997, 157, 317–320. [Google Scholar] [CrossRef]
- Meliconi, R.; Pulsatelli, L.; Uguccioni, M.; Salvarani, C.; Macchioni, P.; Melchiorri, C.; Focherini, M.C.; Frizziero, L.; Facchini, A. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum. 1996, 39, 1199–1207. [Google Scholar] [CrossRef] [PubMed]
- Salvarani, C.; Cantini, F.; Olivieri, I.; Hunder, G.S. Polymyalgia rheumatica: A disorder of extraarticular synovial structures? J. Rheumatol. 1999, 26, 517–521. [Google Scholar]
- Salvarani, C.; Cantini, F.; Olivieri, I.; Barozzi, L.; Macchioni, L.; Niccoli, L.; Padula, A.; De Matteis, M.; Pavlica, P. Proximal bursitis in active polymyalgia rheumatica. Ann. Intern. Med. 1997, 127, 27–31. [Google Scholar] [CrossRef] [PubMed]
- Cantini, F.; Salvarani, C.; Olivieri, I.; Niccoli, L.; Padula, A.; Macchioni, L.; Boiardi, L.; Ciancio, G.; Mastrorosato, M.; Rubini, F.; et al. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: A case-control study. J. Rheumatol. 2001, 28, 1049–1055. [Google Scholar] [PubMed]
- Cantini, F.; Niccoli, L.; Nannini, C.; Padula, A.; Olivieri, I.; Boiardi, L.; Salvarani, C. Inflammatory changes of hip synovial structures in polymyalgia rheumatica. Clin. Exp. Rheumatol. 2005, 23, 462–468. [Google Scholar] [PubMed]
- Salvarani, C.; Barozzi, L.; Cantini, F.; Niccoli, L.; Boiardi, L.; Valentino, M.; Pipitone, N.; Bajocchi, G.; Macchioni, P.; Catanoso, M.G.; et al. Cervical interspinous bursitis in active polymyalgia rheumatica. Ann. Rheum. Dis. 2008, 67, 758–761. [Google Scholar] [CrossRef] [PubMed]
- Salvarani, C.; Barozzi, L.; Boiardi, L.; Pipitone, N.; Bajocchi, G.L.; Macchioni, P.L.; Catanoso, M.; Pazzola, G.; Valentino, M.; De Luca, C.; et al. Lumbar interspinous bursitis in active polymyalgia rheumatica. Clin. Exp. Rheumatol. 2013, 31, 526–531. [Google Scholar] [CrossRef] [PubMed]
- Gonzalez-Gay, M.A. The clinical implication of cervical interspinous bursitis inthe diagnosis of polymyalgia rheumatica. Ann. Rheum. Dis. 2008, 67, 733–734. [Google Scholar] [CrossRef]
- Dasgupta, B.; Cimmino, M.A.; Kremers, H.M.; Schmidt, W.A.; Schirmer, M.; Salvarani, C.; Bachta, A.; Dejaco, C.; Duftner, C.; Jensen, H.S.; et al. 2012 Provisional classification criteria for polymyalgia rheumatica: A European League against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum. 2012, 64, 943–954. [Google Scholar] [CrossRef]
- Macchioni, P.; Boiardi, L.; Catanoso, M.; Pazzola, G.; Salvarani, C. Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: Comparison with the previous criteria in a single-centre study. Ann. Rheum. Dis. 2014, 73, 1190–1193. [Google Scholar] [CrossRef]
- Sakellariou, G.; Iagnocco, A.; Riente, L.; Ceccarelli, F.; Carli, L.; Di Geso, L.; Sedie, A.D.; Filippucci, E.; Montecucco, C. Ultrasound imaging for the rheumatologist XLIII. Ultrasonographic evaluation of shoulders and hips in patients with polymyalgia rheumatica: A systematic literature review. Clin. Exp. Rheumatol. 2013, 31, 1–7. [Google Scholar] [PubMed]
- Betrains, A.; Blockmans, D. Use of 18F-Fluorodeoxyglucose PET in the Diagnosis and Follow-up of Polymyalgia Rheumatica. PET Clin. 2020, 15, 147–152. [Google Scholar] [CrossRef] [PubMed]
- Possemato, N.; Salvarani, C.; Pipitone, N. Imaging in polymyalgia rheumatica. Reumatismo 2018, 70, 51–58. [Google Scholar] [CrossRef] [PubMed]
- Yuge, S.; Nakatani, K.; Yoshino, K.; Koyama, T. Diagnosing polymyalgia rheumatica on 18F-FDG PET/CT: Typical uptake patterns. Ann. Nucl. Med. 2018, 32, 573–577. [Google Scholar] [CrossRef]
- González-Gay, M.Á.; Heras-Recuero, E.; Blázquez-Sánchez, T.; Caraballo-Salazar, C.; Rengifo-García, F.; Castañeda, S.; Largo, R. Broadening the clinical spectrum of giant cell arteritis: From the classic cranial to the predominantly extracranial pattern of the disease. Expert. Rev. Clin. Immunol. 2024; 1–12, epub ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Jamar, F.; van derLaken, C.J.; Panagiotidis, E.; Steinz, M.M.; van derGeest, K.S.M.; Graham, R.N.J.; Gheysens, O. Update on Imaging of In-flammatory Arthritis and Related Disorders. Semin. Nucl. Med. 2023, 53, 287–300. [Google Scholar] [CrossRef]
- Mekenyan, L.; Karalilova, R.; Todorov, P.; Tepeliev, N.; Batalov, A. Imaging methods in polymyalgia rheumatica: A systematic review. Rheumatol. Int. 2023, 43, 825–840. [Google Scholar] [CrossRef]
- Owen, C.E.; Poon, A.M.T.; Liu, B.; Liew, D.F.L.; Yap, L.P.; Yang, V.; Leung, J.L.; McMaster, C.R.; Scott, A.M.; Buchanan, R.R.C. Characterising polymyalgia rheumatica on whole-body 18F-FDG PET/CT: An atlas. Rheumatol. Adv. Pract. 2024, 8, rkae003. [Google Scholar] [CrossRef]
- Gonzalez-Gay, M.A.; Garcia-Porrua, C.; Salvarani, C.; Olivieri, I.; Hunder, G.G. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J. Rheumatol. 2000, 27, 2179–2184. [Google Scholar] [PubMed]
- Paltta, J.; Suuronen, S.; Pirilä, L.; Palomäki, A. Differential diagnostics of polymyalgia rheumatica in a university hospital in Finland. Scand. J. Rheumatol. 2023, 52, 689–695. [Google Scholar] [CrossRef]
- Gheysens, O.; de Ponfilly, M.P.; Nocturne, G.; Seror, R.; Besson, F.L.; Jamar, F. [18F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects. Semin. Nucl. Med. 2023, 54, 371–378. [Google Scholar] [CrossRef] [PubMed]
- van der Geest, K.S.M.; Treglia, G.; Glaudemans, A.W.J.M.; Brouwer, E.; Jamar, F.; Slart, R.H.J.A.; Gheysens, O. Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: A systematic review and meta-analysis. Eur. J. Nucl. Med. Mol. Imaging 2021, 48, 1876–1889. [Google Scholar] [CrossRef] [PubMed]
- Camellino, D.; Paparo, F.; Morbelli, S.D.; Pesce, G.; Bauckneht, M.; Bagnasco, M.; Cutolo, M.; Sambuceti, G.; Cimmino, M.A. Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica. Clin. Exp. Rheumatol. 2022, 40, 78–85. [Google Scholar] [CrossRef] [PubMed]
- Kim, K.; Kim, S.-J. Diagnostic performance of F-18 fluorodeoxyglucose PET/computed tomography for diagnosis of polymyalgia rheumatica: A meta-analysis. Nucl. Med. Commun. 2020, 41, 1313–1321. [Google Scholar] [CrossRef] [PubMed]
- Amat, J.; Chanchou, M.; Olagne, L.; Descamps, L.; Flaus, A.; Bouvet, C.; Barres, B.; Valla, C.; Molnar, L.; Cougoul, A.; et al. Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography in Inflammatory Rheumatism, Particularly Polymyalgia Rheumatica: A Retrospective Study of 222 PET/CT. Front. Med. 2020, 7, 394. [Google Scholar] [CrossRef] [PubMed]
- Moreel, L.; Boeckxstaens, L.; Betrains, A.; Van Hemelen, M.; Vanderschueren, S.; Van Laere, K.; Blockmans, D. Diagnostic accuracy and validation of 18F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica. Front. Med. 2022, 9, 1026944. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- van der Geest, K.S.M.; van Sleen, Y.; Nienhuis, P.; Sandovici, M.; Westerdijk, N.; Glaudemans, A.W.J.M.; Brouwer, E.; Slart, R.H.J.A. Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica. Rheumatology 2022, 61, 1072–1082. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Sondag, M.; Guillot, X.; Verhoeven, F.; Blagosklonov, O.; Prati, C.; Boulahdour, H.; Wendling, D. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: A controlled study. Rheumatology 2016, 55, 1452–1457. [Google Scholar] [CrossRef]
- Flaus, A.; Amat, J.; Prevot, N.; Olagne, L.; Descamps, L.; Bouvet, C.; Barres, B.; Valla, C.; Mathieu, S.; Andre, M.; et al. Decision Tree with Only Two Musculoskeletal Sites to Diagnose Polymyalgia Rheumatica Using [18F]FDG PET-CT. Front. Med. 2021, 8, 646974. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Owen, C.E.; Poon, A.M.T.; Yang, V.; McMaster, C.; Lee, S.T.; Liew, D.F.L.; Leung, J.L.; Scott, A.M.; Buchanan, R.R.C. Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity. Eur. J. Nucl. Med. Mol. Imaging 2020, 47, 2461–2468. [Google Scholar] [CrossRef] [PubMed]
- Brinth, L.S.; Hansen, A.; Jensen, D.V.; Madsen, O.R.; Broholm, R.; Krakauer, M. Diagnostic Value of Composite and Simplified FDG-PET/CT Scores in Polymyalgia Rheumatica and the Influence of Recent Glucocorticoid Treatment—A Retrospective Diagnostic Cohort Study. Diagnostics 2023, 13, 514. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ikuma, D.; Sawa, N.; Yamanouchi, M.; Oba, Y.; Mizuno, H.; Suwabe, T.; Hoshino, J.; Ubara, Y. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression tree analysis. Mod. Rheumatol. 2024, 34, 474–478. [Google Scholar] [CrossRef] [PubMed]
- Casadepax-Soulet, C.; Benali, K.; Crestani, B.; Piekarski, E.; Mahida, B.; Ebstein, E.; Juge, P.-A.; Forien, M.; Dieudé, P.; Ottaviani, S. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: An observational study. Clin. Exp. Rheumatol. 2023, 41, 1456–1462. [Google Scholar] [CrossRef] [PubMed]
- Henckaerts, L.; Gheysens, O.; Vanderschueren, S.; Goffin, K.; Blockmans, D. Use of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica—A prospective study of 99 patients. Rheumatology 2018, 57, 1908–1916. [Google Scholar] [CrossRef] [PubMed]
- Yamashita, H.; Kubota, K.; Takahashi, Y.; Minaminoto, R.; Morooka, M.; Ito, K.; Kano, T.; Kaneko, H.; Takashima, H.; Mimoiri, A. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: Evidence for distinctive bursitis and large-vessel vasculitis. Mod. Rheumatol. 2012, 22, 705–711. [Google Scholar] [CrossRef] [PubMed]
- Heras-Recuero, E.; Landaeta-Kancev, L.C.; de Bourio-Allona, M.M.; Torres-Rosello, A.; Blázquez-Sánchez, T.; Ferraz-Amaro, I.; Castañeda, S.; Martínez-López, J.A.; Martínez-Dhier, L.; Largo, R.; et al. Positron Emission Computed Tomography Spectrum of Large Vessel Vasculitis in a Tertiary Center: Differences in 18F-fluorodeoxyglucose Uptake between Large Vessel Vasculitis with Predominant Cranial and Extracranial Giant Cell Arteritis Phenotypes. J. Clin. Med. 2023, 12, 6164. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Heras-Recuero, E.; de Bourio-Allona, M.M.; Landaeta-Kancev, L.C.; Blázquez-Sánchez, T.; Torres-Roselló, A.; Álvarez-Rubio, M.; Belhaj-Gandar, M.; Martínez-López, J.A.; Martínez-Dhier, L.; Llorca, J.; et al. 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell Arteritis. J. Clin. Med. 2023, 12, 6983. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Slart, R.H.J.A.; Nienhuis, P.H.; Glaudemans, A.W.J.M.; Brouwer, E.; Gheysens, O.; van der Geest, K.S.M. Role of 18F-FDG PET/CT in Large Vessel Vasculitis and Polymyalgia Rheumatica. J. Nucl. Med. 2023, 64, 515–521. [Google Scholar] [CrossRef] [PubMed]
- Gorlen, T.F.; Brittain, J.M.; Østergaard, M.; Fischer, B.M.; Døhn, U.M.; Terslev, L. Low incidence of malignancy in patients with suspected polymyalgia rheumatica or giant cell arteritis, examined with FDG-PET/CT. Front. Med. 2024, 11, 1309905. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Abdel-Wahab, N.; Suarez-Almazor, M.E. Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy. Expert Rev. Clin. Immunol. 2024, 1–21. [Google Scholar] [CrossRef] [PubMed]
- Liew, D.F.L.; Mackie, S.L.; Tison, A.; Sattui, S.E.; Yates, M.; Buchanan, R.R.C.; Owen, C.E.; Liew, D.F.; Mackie, S.L.; Tison, A.; et al. Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica. Rheum. Dis. Clin. N. Am. 2024, 50, 255–267. [Google Scholar] [CrossRef] [PubMed]
- Vermeulen, O.C.B.; Brouwer, E.; Slart, R.H.J.A.; Sandovici, M.; Rutgers, A.; Hilterman, T.J.; Hiddinga, B.; Oosting, S.F.; Jalving, M.; de Heij, A.H.; et al. Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: Comparison of disease characteristics and treatment requirement. Rheumatology 2024, keae099. [Google Scholar] [CrossRef] [PubMed]
- Desvages, A.; Hives, F.; Deprez, X.; Pierache, A.; Béhal, H.; Flipo, R.-M.; Paccou, J. Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in Diagnosing Polymyalgia Rheumatica and Large-Vessel Vasculitis: A Case-Control Study. J. Clin. Med. 2023, 12, 2844. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ponte, C.; Martins-Martinho, J.; Luqmani, R.A. Diagnosis of giant cell arteritis. Rheumatology 2020, 59 (Suppl. 3), iii5–iii16. [Google Scholar] [CrossRef] [PubMed]
- van der Geest, K.S.M.; Slijkhuis, B.G.C.; Tomelleri, A.; Gheysens, O.; Jiemy, W.F.; Piccolo, C.; Nienhuis, P.; Sandovici, M.; Brouwer, E.; Glaudemans, A.W.; et al. Positron Emission Tomography Imaging in Vasculitis. Cardiol. Clin. 2023, 41, 251–265. [Google Scholar] [CrossRef] [PubMed]
- Germanò, G.; Versari, A.; Muratore, F.; Pipitone, N.; Bajocchi, G.L.; Catanoso, M.G.; Salvarani, C. Isolated vasculitis of the lower extremities in a patient with polymyalgia rheumatica and giant cell arteritis. Clin. Exp. Rheumatol. 2011, 29 (Suppl. 64), S138–S139. [Google Scholar] [PubMed]
- Dejaco, C.; Ramiro, S.; Bond, M.; Bosch, P.; Ponte, C.; Mackie, S.L.; Bley, T.A.; Blockmans, D.; Brolin, S.; Bolek, E.C.; et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann. Rheum. Dis. 2023, 83, 741–751. [Google Scholar] [CrossRef] [PubMed]
- Prieto-Peña, D.; Martínez-Rodríguez, I.; Loricera, J.; Banzo, I.; Calderón-Goercke, M.; Calvo-Río, V.; González-Vela, C.; Corrales, A.; Castañeda, S.; Blanco, R.; et al. Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica. Semin. Arthritis Rheum. 2019, 48, 720–727. [Google Scholar] [CrossRef] [PubMed]
- Rehak, Z.; Sprlakova-Pukova, A.; Kazda, T.; Fojtik, Z.; Vargova, L.; Nemec, P. 18F-FDG PET/CT in polymyalgia rheumatica—A pictorial review. Br. J. Radiol. 2017, 90, 20170198. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Kubota, K.; Yamashita, H.; Mimori, A. Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis. Semin. Nucl. Med. 2017, 47, 408–424. [Google Scholar] [CrossRef] [PubMed]
- Pean de Ponfilly–Sotier, M.; Besson, F.L.; Gomez, L.; Ottaviani, S.; Dieudé, P.; Pavy, S.; Mariette, X.; Seror, R.; Nocturne, G. Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice. Jt. Bone Spine 2022, 89, 105325. [Google Scholar] [CrossRef] [PubMed]
- Emamifar, A.; Hess, S.; Gerke, O.; Hermann, A.P.; Laustrup, H.; Hansen, P.S.; Thye-Rønn, P.; Marcussen, N.; Svendstrup, F.; Gildberg-Mortensen, R.; et al. Polymyalgia rheumatica and giant cell arteritis—Three challenges—Consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol. Medicine 2017, 96, e7297. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Stellingwerff, M.D.; Brouwer, E.; Lensen, K.D.F.; Rutgers, A.; Arends, S.; van der Geest, K.S.M.; Glaudemans, A.W.J.M.; Slart, R.H.J.A. Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization. Medicine 2015, 94, e1542. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Nielsen, B.D.; Gormsen, L.C.; Hansen, I.T.; Keller, K.K.; Therkildsen, P.; Hauge, E.-M. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. Eur. J. Nucl. Med. Mol. Imaging 2018, 45, 1119–1128. [Google Scholar] [CrossRef] [PubMed]
- Nielsen, A.W.; Hansen, I.T.; Nielsen, B.D.; Kjær, S.G.; Blegvad-Nissen, J.; Rewers, K.; Sørensen, C.M.; Hauge, E.-M.; Gormsen, L.C.; Keller, K.K. The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET/CT in polymyalgia rheumatica—A prospective study of 101 patients. Eur. J. Nucl. Med. Mol. Imaging 2024, 51, 2614–2624. [Google Scholar] [CrossRef] [PubMed]
- Blockmans, D.; De Ceuninck, L.; Vanderschueren, S.; Knockaert, D.; Mortelmans, L.; Bobbaers, H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: A prospective study in 35 patients. Rheumatology 2007, 46, 672–677. [Google Scholar] [CrossRef] [PubMed]
- Camellino, D.; Cimmino, M.A. Imaging of polymyalgia rheumatica: Indications on its pathogenesis, diagnosis and prognosis. Rheumatology 2012, 51, 77–86. [Google Scholar] [CrossRef] [PubMed]
- Dejaco, C.; Singh, Y.P.; Perel, P.; Hutchings, A.; Camellino, D.; Mackie, S.; Abril, A.; Bachta, A.; Balint, P.; Barraclough, K.; et al. 2015 Recommendations for the management of polymyalgia rheumatica: A European League against Rheumatism/American College of Rheumatology collaborative initiative. Ann. Rheum. Dis. 2015, 74, 1799–1807. [Google Scholar] [CrossRef] [PubMed]
- Emamifar, A.; Ellingsen, T.; Hess, S.; Gerke, O.; Hviid Larsen, R.; Ahangarani Farahani, Z.; Syrak Hansen, P.; Jensen Hansen, I.M.; Petersen, H.; Marcussen, N.; et al. The Utility of 18F-FDG PET/CT in Patients with Clinical Suspicion of Polymyalgia Rheumatica and Giant Cell Arteritis: A Prospective, Observational, and Cross-sectional Study. ACR Open Rheumatol. 2020, 2, 478–490. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Salvarani, C.; Padoan, R.; Iorio, L.; Tomelleri, A.; Terrier, B.; Muratore, F.; Dasgupta, B. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases? Autoimmun. Rev. 2024, 23, 103415. [Google Scholar] [CrossRef] [PubMed]
- Galli, E.; Muratore, F.; Mancuso, P.; Boiardi, L.; Marvisi, C.; Besutti, G.; Spaggiari, L.; Casali, M.; Versari, A.; Rossi, P.G.; et al. The role of PET/CT in disease activity assessment in patients with large vessel vasculitis. Rheumatology 2022, 61, 4809–4816. [Google Scholar] [CrossRef] [PubMed]
- Noriega-Álvarez, E.; Rodríguez-Alfonso, B.; Merino Argumánez, C.; Domínguez Gadea, L.; Peiró-Valgañón, V. Decoding poly-myalgia rheumatica, the role of Nuclear Medicine Imaging. Rev. Esp. Med. Nucl. Imagen. Mol. (Engl. Ed.) 2024, 43, 63–72. [Google Scholar] [CrossRef] [PubMed]
- García, A.G.; Fabregate, M.; Serralta, G.; de Miguel Campo, B.; Mozo, A.N.; Robles-Marhuenda, Á. The utility of 18F-FDG-PET/CT in detecting extracranial large vessel vasculitis in rheumatic polymyalgia or giant cell arteritis: A systematic review and meta-analysis. Rev. Clin. Esp. 2024, in press. [CrossRef]
- Clifford, A.H.; Cimmino, M.A. In search of a diagnostic test for polymyalgia rheumatica: Is positron emission tomography the answer? Rheumatology 2018, 57, 1881–1882. [Google Scholar] [CrossRef] [PubMed]
Typical clinical manifestations but normal markers of inflammation |
Patients with typical clinical features who do not experience adequate response to glucocorticoids |
Patients with suspected PMR with atypical presentation |
Suspected large vessel vasculitis indicative of extracranial GCA |
To exclude other conditions that can mimic PMR (i.e., malignancies, infections, rheumatoid arthritis, and atypical spondyloarthritis) |
PMR-like syndrome in cancer patients treated with immune checkpoint inhibitors (ICIs) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Heras-Recuero, E.; Blázquez-Sánchez, T.; Landaeta-Kancev, L.C.; Martínez de Bourio-Allona, M.; Torres-Roselló, A.; Rengifo-García, F.; Caraballo-Salazar, C.; Largo, R.; Castañeda, S.; González-Gay, M.Á. Positron Emission Tomography/Computed Tomography in Polymyalgia Rheumatica: When and for What—A Critical Review. Diagnostics 2024, 14, 1539. https://doi.org/10.3390/diagnostics14141539
Heras-Recuero E, Blázquez-Sánchez T, Landaeta-Kancev LC, Martínez de Bourio-Allona M, Torres-Roselló A, Rengifo-García F, Caraballo-Salazar C, Largo R, Castañeda S, González-Gay MÁ. Positron Emission Tomography/Computed Tomography in Polymyalgia Rheumatica: When and for What—A Critical Review. Diagnostics. 2024; 14(14):1539. https://doi.org/10.3390/diagnostics14141539
Chicago/Turabian StyleHeras-Recuero, Elena, Teresa Blázquez-Sánchez, Laura Cristina Landaeta-Kancev, Marta Martínez de Bourio-Allona, Arantxa Torres-Roselló, Fernando Rengifo-García, Claritza Caraballo-Salazar, Raquel Largo, Santos Castañeda, and Miguel Ángel González-Gay. 2024. "Positron Emission Tomography/Computed Tomography in Polymyalgia Rheumatica: When and for What—A Critical Review" Diagnostics 14, no. 14: 1539. https://doi.org/10.3390/diagnostics14141539
APA StyleHeras-Recuero, E., Blázquez-Sánchez, T., Landaeta-Kancev, L. C., Martínez de Bourio-Allona, M., Torres-Roselló, A., Rengifo-García, F., Caraballo-Salazar, C., Largo, R., Castañeda, S., & González-Gay, M. Á. (2024). Positron Emission Tomography/Computed Tomography in Polymyalgia Rheumatica: When and for What—A Critical Review. Diagnostics, 14(14), 1539. https://doi.org/10.3390/diagnostics14141539